Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | TRVI | RARE | ||
| Company | Myovant Sciences Ltd | Trevi Therapeutics Inc | Ultragenyx Pharmaceu | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 26.99 | 18.59 | 28.39 | ||
| High | 27.00 | 18.90 | 28.50 | ||
| Low | 26.98 | 18.47 | 25.64 | ||
| Last | 26.98 | 18.79 | 25.68 | ||
| Change | -0.01 | -0.02 | -0.56 | ||
| Percent Change | -0.04% | -0.11% | -2.13% | ||
| Volume | 2,256,000 | 279,633 | 1,377,105 | ||
| 20-Day Average Volume | 1,234,240 | 1,522,898 | 1,973,161 | ||
| Previous | 26.99 | 18.81 | 26.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 18.30 | 26.03 | ||
| 20-Day Raw Stochastic | 50.00% | 79.41% | 46.09% | ||
| 20-Day Relative Strength | 61.08 | 56.73 | 45.79 | ||
| Weighted Alpha | +96.20 | +140.96 | +1.51 | ||
| Today's Opinion | 100% Buy | 100% Buy | 16% Sell | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Last Month's Opinion | 96% Buy | 88% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | +3.64% since 08/13/26 | -1.14% since 08/13/26 | ||
| Low | 26.95 on 03/06/23 | 17.63 on 08/14/26 | 24.97 on 08/18/26 | ||
| High | 27.00 on 03/09/23 | 19.30 on 08/19/26 | 28.50 on 08/20/26 | ||
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | +12.16% since 07/20/26 | -8.59% since 07/20/26 | ||
| Low | 26.90 on 02/13/23 | 16.92 on 07/24/26 | 24.01 on 08/03/26 | ||
| High | 27.06 on 02/13/23 | 19.30 on 08/19/26 | 29.10 on 07/21/26 | ||
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | +35.52% since 05/20/26 | +11.59% since 05/20/26 | ||
| Low | 26.75 on 12/16/22 | 13.20 on 06/09/26 | 21.33 on 06/02/26 | ||
| High | 27.06 on 02/13/23 | 20.22 on 07/17/26 | 36.57 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | +76.79% since 02/20/26 | +14.79% since 02/20/26 | ||
| Low | 16.26 on 09/23/22 | 10.25 on 03/24/26 | 18.29 on 03/24/26 | ||
| High | 27.06 on 02/13/23 | 20.22 on 07/17/26 | 36.57 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 2,679,973 | 2,586,975 | ||
| Shares Outstanding, K | 97,235 | 142,476 | 98,589 | ||
| Annual Sales, $M | 230,970,000 | 0 | 673,000,000 | ||
| Annual Net Income, $M | -205,980,000 | -42,760,000 | -575,000,000 | ||
| Last Qtr Sales, $M | 100,230,000 | 0 | 214,000,000 | ||
| Last Qtr Income, $M | -57,630,000 | -17,800,000 | -92,000,000 | ||
| 60-Month Beta | 2.17 | 1.03 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | -0.11 on 08/06/26 | -0.90 on 08/04/26 | ||
| Latest Earnings Date | 05/09/23 | 11/12/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||